BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Influenza
,
Leukocyte
,
Anticancer prodrugs
,
Clofibrate
,
rs4950928
,
DRD2
,
Angiogenesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Efp
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Placenta
Ascending colon
Spleen
Transverse colon
Colon
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
TRIM25 inhibition attenuates inflammation, senescence, and oxidative stress in microvascular endothe…
TRIM25 Rescues Against Doxorubicin-Induced Pyroptosis Through Promoting NLRP1 Ubiquitination.
ATAD2 drives colorectal cancer progression by regulating TRIM25 expression via a positive feedback l…
Long noncoding RNA AVAN promotes antiviral innate immunity by interacting with TRIM25 and enhancing …
OTUD5 cooperates with TRIM25 in transcriptional regulation and tumor progression via deubiquitinatio…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Durability and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women
A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 2)
A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 1)
Safety and Effectiveness of EN3835 in the Treatment of EFP in Women
Safety and Pharmacokinetics of a Single Dose of CCH (3.36 mg) in Subjects With EFP
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ